Need a specific person's email?
Browse Invivyd's employee directory (about 187 employees) and reveal verified emails free.
Invivyd's most common email format is FLast@invivyd.com (ex. JDoe@invivyd.com), used for 97% of invivyd.com addresses. Invivyd uses 6 email patterns across 2 domains: invivyd.com and adagiotx.com. Percentages are the share of addresses within each domain.
| Format | Example | Share of invivyd.com |
|---|---|---|
| FLast@invivyd.comMost common | JDoe@invivyd.com | |
| First.Last@invivyd.com | John.Doe@invivyd.com |
| Format | Example | Share of adagiotx.com |
|---|---|---|
| First.Last@adagiotx.comMost common | John.Doe@adagiotx.com | |
| FLast@adagiotx.com | JDoe@adagiotx.com | |
| FirstLast@adagiotx.com | JohnDoe@adagiotx.com | |
| FirstLas@adagiotx.com | JohnDoe@adagiotx.com |
Browse Invivyd's employee directory (about 187 employees) and reveal verified emails free.
Biotechnology ResearchConnecticut, United States51-200 Employees
Invivyd is a biotechnology company based in New Haven, Connecticut, focused on developing antibody-based medicines designed to be highly potent and more resilient to viral evolution than the human immune system. The company uses a proprietary, integrated technology platform to guide the discovery, development, monitoring, and adaptation of antibodies, aiming to deliver preventive therapies with strong protective potential. Operating as a mid-sized organization, it concentrates on monoclonal antibodies within the biotechnology research sector. Its work centers on preventing COVID-19 with antibody therapies, offering a vaccine-alternative option and exploring co-administration with vaccines in clinical trials. In June 2026, the company announced that the LIBERTY Phase 3 trial began dosing participants to evaluate the antibody alone, the vaccine alone, and their combination.
Most common format
FLast@invivyd.com
Example: JDoe@invivyd.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.